Earnings Feed
Sign Up
Home/Insiders/AKKARAJU SRINIVAS
AS
SEC Insider//CIK 0001253170

AKKARAJU SRINIVAS

CIK 00012531704 companiesNEW YORK, NY
SEC Profile

Transactions

32

Companies

4

Filings

5

CIK

0001253170

Recent Transactions

32 trades
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-04$8.18/sh+66,027→ 1,078,876 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-04$8.18/sh+66,027→ 1,078,876 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-03$7.75/sh+100,000→ 1,012,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-03$7.75/sh+100,000→ 1,012,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-02$7.55/sh+96,000→ 912,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-02$7.55/sh+96,000→ 912,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-01$7.46/sh+86,350→ 816,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-12-01$7.46/sh+86,350→ 816,849 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-11-28$7.64/sh+38,702→ 730,499 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-11-28$7.64/sh+38,702→ 730,499 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-11-26$7.64/sh+48,537→ 691,797 total
  • Purchase
    ALUMIS INC.$ALMS

    Common Stock

    2025-11-26$7.64/sh+48,537→ 691,797 total
  • Award
    EYETECH PHARMACEUTICALS INC

    Common Stock

    2005-06-28$0.01/sh+17,500→ 2,275,896 total
  • Award
    EYETECH PHARMACEUTICALS INC

    Common Stock

    2005-06-28$0.01/sh+17,500→ 2,275,896 total
  • Purchase
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-12-30$7.94/sh+147,134→ 147,134 total
  • Sale
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-12-30$7.94/sh−147,134→ 2,323,666 total
  • Sale
    Seagen Inc.

    Warrants

    2004-12-30$123003.49/sh−38,114→ 601,925 total
  • Purchase
    Seagen Inc.

    Warrants

    2004-12-30$123003.49/sh+38,114→ 381,140 total
  • Sale
    Seagen Inc.

    Series A Convertible Preferred Stock

    2004-12-30$22.80/sh−30,491→ 4,815,400 total
  • Sale
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-12-30$7.94/sh−147,134→ 2,323,666 total
  • Purchase
    Seagen Inc.

    Series A Convertible Preferred Stock

    2004-12-30$22.80/sh+30,491→ 304,910 total
  • Purchase
    Seagen Inc.

    Series A Convertible Preferred Stock

    2004-12-30$22.80/sh+30,491→ 304,910 total
  • Sale
    Seagen Inc.

    Warrants

    2004-12-30$123003.49/sh−38,114→ 601,925 total
  • Purchase
    Seagen Inc.

    Warrants

    2004-12-30$123003.49/sh+38,114→ 381,140 total
  • Sale
    Seagen Inc.

    Series A Convertible Preferred Stock

    2004-12-30$22.80/sh−30,491→ 4,815,400 total
  • Purchase
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-12-30$7.94/sh+147,134→ 147,134 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-04-28+2,470,800→ 2,470,800 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Series B Convertible Preferred Stock

    2004-04-28+4,201,280→ 0 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Series C Convertible Preferred Stock

    2004-04-28+740,321→ 0 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Series C Convertible Preferred Stock

    2004-04-28+740,321→ 0 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Common Stock

    2004-04-28+2,470,800→ 2,470,800 total
  • Conversion
    BARRIER THERAPEUTICS INC

    Series B Convertible Preferred Stock

    2004-04-28+4,201,280→ 0 total

Companies

4

Recent Filings

5

Address

C/O JPMORGAN PARTNERS 1221 AVE OF THE AMERICAS

NEW YORK, NY, 10020

View on SEC.gov